|  
               
              Ocular 
              Microbiology and Immunology Group 
              Back 
              to OMIG Main Page 
            2011 
            Abstract List | < Previous 
            2011 
            OMIG Abstract 28  
            Management and outcome of Pseudomonas aerugionosa keratoscleritis and scleritis  
L.H. Suh, G. Amescua, N. Stanciu, T.A. Albini,  D. Miller, R.K. Forster  
Bascom Palmer Eye Institute,  University of Miami, Miller School of Medicine, Miami, FL  
            Purpose: To  describe the clinical presentation and course of patients with culture proven Pseudomonas  aeruginosa scleritis and keratoscleritis at our institution.  
            Methods: A retrospective case series review from  January 2006 through December 2010 was performed, identifying all patients  managed by the authors with culture proven Pseudomonas aeruginosa keratoscleritis and scleritis. Clinical  findings, therapeutic interventions, visual outcomes and complications were reviewed. 
            Results: A total of seven cases are included in this  study. The Pseudomonas infections included four cases of keratoscleritis  and three cases of scleritis with five male and two female patients, and a mean  age of 69.5 +/- 11.  Prior pterygium  surgery with radiation or mitomycin C was the most common risk factor, followed  by soft contact lens use, prior glaucoma surgery, and organic trauma. Systemic  fluoroquinolones were used in all patients. Topical steroids were used in all  patients once cultures were positive for P. aeruginosa. Systemic  steroids were used in three patients. All patients received aggressive medical  management with topical fortified tobramycin, a topical 4th  generation fluoroquinolone, and systemic antibiotics of the fluoroquinolone  family. Four patients had acute surgical intervention consisting of  conjunctival resection, antibiotic irrigation and cryotherapy. One patient  required a scleral patch graft after cryotherapy due to significant scleral  thinning. Retinal detachment occurred in one patient and required a scleral  buckle, pars plana vitrectomy and penetrating keratplasty. After treatment, all patients improved without  evisceration or enucleation. The mean final visual acuity was 0.95 logMAR +/-  0.3. 
            Conclusions: The visual  prognosis of Pseudomonas aeruginosa keratoscleritis and scleritis  remains poor. Aggressive medical treatment and, when possible, acute surgical  intervention is necessary. The availability of systemic fluoroquinolones may be  the reason for better outcomes in these patients compared to historical  reports. The role of systemic and/or topical steroids remains controversial.   
            Disclosures: N 
            2011 
            Abstract List | < Previous 
            
            
             |